Brief: Enochian Biosciences Announces Receipt Of Notice From Nasdaq Regarding Delayed Filing Of Form 10-Q For The Period Ended September 30, 2022
30/11/2022 22:25
Nov 30 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES ANNOUNCES RECEIPT OF NOTICE FROM
NASDAQ
REGARDING DELAYED FILING OF FORM 10-Q FOR THE PERIOD ENDED
SEPTEMBER 30, 2022
Source text for Eikon: ID:nGNX6qq4Sp
Further company coverage: ENOB.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing